NCBI PubMed Central
open access
Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vergleich einer Parkinson-Kohorte mit einer Nicht-Parkinson-Kohorte hinsichtlich psychosozialer und körperlicher Auswirkungen der COVID-19-Pandemie / Lisa-Marie Chidex ; Gutachter: Thomas Bahmer ; Betreuer: Walter Mätzler#664605
- SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)#1115168
- Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.#889950
- 38 U.S.C. § 7329 — Parkinson’s Disease research, education, and clinical centers#587933
- Knowledge and Misconceptions About Parkinson's Disease in Lebanon: A Cross-Sectional Survey.#354930
Record · ID 659724
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive